Prostate cancer study proves the drug dutasteride delays disease progression
Tuesday, January 24th, 2012 Posted in prostate cancer, watchful waiting | No Comments »Good news coming from University Health Network for men diagnosed with low-risk, localized prostate cancer. Results of a three-year international clinical trial show that being treated with the drug dutasteride ("Avodart") delays disease progression and initiating active treatment, and also ...
First genetic mutation linked to an inherited form of prostate cancer
Sunday, January 15th, 2012 Posted in prostate cancer | No Comments »According to University of North Carolina researchers, the mutation is significantly more common in men with a family history of prostate cancer that strikes at an earlier age, compared to older patients with no family history.While more study is needed, ...
Researchers find familial prostate cancer gene mutation
Friday, January 13th, 2012 Posted in prostate cancer | No Comments »A new study at Johns Hopkins University School of Medicine has found that men who inherit a rare genetic mutation are 10 to 20 times more likely than average to develop prostate cancer. The gene variant may help explain cases ...
New prostate cancer care approach draws patients with riskiest disease
Thursday, January 5th, 2012 Posted in prostate cancer | No Comments »Duke Cancer Institute researchers suggests that in choosing where they get treatment, prostate cancer patients tend to opt for a major cancer center if they have severe disease, but stick closer to home for less complicated cases, even when offered ...
Urgent need for more research in prostate cancer treatment
Thursday, December 15th, 2011 Posted in prostate cancer | No Comments »A panel of experts convened by the National Institutes of Health concluded recently the treatment of prostate cancer may be worse than the disease itself in a growing percentage of men diagnosed with this disease. Surgery or radiation can cure prostate cancer, ...
Hunger hormone could identify prostate cancer
Sunday, December 11th, 2011 Posted in prostate cancer | No Comments »Non-invasive imaging detects prostate cancer earlier than ever before, but can't accurately distinguish between malignant and benign disease. According to new research at Lawson Health Research Institute, a new molecular imaging probe could be the answer. Researchers say malignant prostate cancer ...
What wakes dormant prostate tumor cells
Thursday, December 1st, 2011 Posted in prostate cancer | No Comments »According to a study published online this week in the Journal of Experimental Medicine, prostate tumor cells can be lulled to sleep by a factor released by bone cells. Researchers at Southern Illinois University School of Medicine now show that BMP7, ...
Math may guide prostate cancer treatments in the future
Thursday, November 24th, 2011 Posted in prostate cancer | No Comments »Ohio scientists have designed a first draft of a mathematical model that someday could guide treatment decisions for advanced prostate cancer, in part by helping doctors predict how individual patients will respond to therapy based on the biology of their ...
Surgeons need way to measure post-treatment levels of urinary continence
Wednesday, November 23rd, 2011 Posted in prostate cancer | No Comments »A new paper published by researchers from Sweden’s prestigious Karolinska Institute and related institutions makes it increasingly clear that experts haven’t been able to work out a really good way to measure real urinary continence after radical prostatectomy. The problem is that without a ...
Prostate cancer treatments might be guided soon by math
Tuesday, November 22nd, 2011 Posted in prostate cancer | No Comments »Scientists have designed a first draft of a mathematical model that someday could guide treatment decisions for advanced prostate cancer, in part by helping doctors predict how individual patients will respond to therapy based on the biology of their tumors.These ...